![Ying Xia Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ying Xia Li
Direktor/Vorstandsmitglied bei Wuhan Canvest Biotechnology Co., Ltd.
Aktive Positionen von Ying Xia Li
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Wuhan Canvest Biotechnology Co., Ltd.
![]() Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Direktor/Vorstandsmitglied | 24.07.2020 | - |
Corporate Officer/Principal | - | - | |
Vorsitzender | 01.08.2015 | 01.09.2019 |
Karriereverlauf von Ying Xia Li
Ausbildung von Ying Xia Li
Wuhan University | Graduate Degree |
Statistik
International
China | 3 |
Operativ
Director/Board Member | 1 |
Chairman | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Wuhan Canvest Biotechnology Co., Ltd.
![]() Wuhan Canvest Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Canvest Biotechnology Co., Ltd. engages in the businesses of biological product cell quality testing and biosafety assessment. It provides cell bank construction & preservation, cell verification, production process virus removal & inactivation verification, and corresponding third-party services for biosafety assessment. The company’s technical service items include bacteria & fungus sterility check, mycoplasma examination, internal & exogenous factor inspection, and tumorigenicity test. Wuhan Canvest Biotechnology was founded by Cong Yi Zheng, Geng Fu Xiao, Xiao Bing Xia, Xiang Dong Chen and Xiao Xiong Wu on April 20, 2011 and is headquartered in Wuhan, China. | Health Technology |
- Börse
- Insiders
- Ying Xia Li
- Erfahrung